Business Wire

Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases ...
Morningstar

Octave MSDA Test Gains NY State Certification, Expanding Access Nationwide

Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today the Octave Multiple ...
Morningstar

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the ...

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States Collaboration ...